Chemical Name: (4S,5R)-N-(4-Bromophenyl)-3-oxo-4,5-diphenyl-1-pyrazolidinecarboxamide
Biological ActivitySelective CCK2 receptor antagonist (IC50 values are 16 and > 30,000 nM for CCK2 and CCK1 respectively). Displays anxiolytic and antipsychotic properties in vivo.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
CCK, schizophrenia, and anxiety. CCK-B antagonists inhibit the activity of brain DA neurons.
Central nervous system characterization of the new cholecystokininB antagonist LY288513.
Helton et al.
Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain DA neurons.
Rasmussen et al.
Citation for LY 288513
The citations listed below are publications that use Tocris products. Selected citations for LY 288513 include:
1 Citation: Showing 1 - 1
Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular mor. dependence.
Authors: Wen Et al.
Front Endocrinol (Lausanne) 2012;13:63
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
VersaClone cDNA Plasmids
Reviews for LY 288513
There are currently no reviews for this product. Be the first to review LY 288513 and earn rewards!
Have you used LY 288513?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image